Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 19 | 2024 | 1020 | 2.350 |
Why?
|
| Shock, Cardiogenic | 5 | 2026 | 176 | 2.240 |
Why?
|
| Heart Failure | 25 | 2025 | 2332 | 1.940 |
Why?
|
| Ventricular Function, Left | 10 | 2020 | 549 | 1.390 |
Why?
|
| Myocardium | 9 | 2019 | 852 | 1.300 |
Why?
|
| Heart Ventricles | 9 | 2018 | 749 | 0.990 |
Why?
|
| Myocardial Ischemia | 6 | 2019 | 307 | 0.950 |
Why?
|
| Coronary Thrombosis | 1 | 2025 | 33 | 0.920 |
Why?
|
| Cytokines | 2 | 2021 | 1339 | 0.880 |
Why?
|
| Cardiomyopathies | 5 | 2019 | 514 | 0.870 |
Why?
|
| Thrombectomy | 1 | 2025 | 117 | 0.860 |
Why?
|
| Proteome | 2 | 2024 | 285 | 0.840 |
Why?
|
| Recovery of Function | 5 | 2017 | 449 | 0.820 |
Why?
|
| Acute Coronary Syndrome | 1 | 2025 | 235 | 0.750 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 226 | 0.740 |
Why?
|
| Biomarkers | 5 | 2024 | 3385 | 0.690 |
Why?
|
| Hemodynamics | 4 | 2024 | 810 | 0.660 |
Why?
|
| Oxygenators, Membrane | 1 | 2020 | 3 | 0.660 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2026 | 682 | 0.630 |
Why?
|
| Proteomics | 1 | 2024 | 615 | 0.600 |
Why?
|
| Inflammation | 3 | 2024 | 1489 | 0.600 |
Why?
|
| Lymphocytes | 1 | 2020 | 344 | 0.580 |
Why?
|
| Neutrophils | 1 | 2020 | 371 | 0.550 |
Why?
|
| Coronary Circulation | 5 | 2025 | 187 | 0.530 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2015 | 130 | 0.500 |
Why?
|
| Ventricular Remodeling | 4 | 2020 | 155 | 0.440 |
Why?
|
| Diastole | 2 | 2015 | 181 | 0.440 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 362 | 0.430 |
Why?
|
| Time Factors | 10 | 2025 | 6196 | 0.400 |
Why?
|
| Middle Aged | 25 | 2026 | 28601 | 0.360 |
Why?
|
| Machine Learning | 2 | 2025 | 387 | 0.300 |
Why?
|
| Aged | 15 | 2026 | 21025 | 0.280 |
Why?
|
| Myocardial Infarction | 3 | 2026 | 999 | 0.260 |
Why?
|
| Male | 27 | 2026 | 64957 | 0.260 |
Why?
|
| Myocardial Contraction | 4 | 2017 | 241 | 0.260 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12936 | 0.250 |
Why?
|
| Humans | 37 | 2026 | 131163 | 0.250 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2025 | 45 | 0.240 |
Why?
|
| RNA | 2 | 2023 | 517 | 0.240 |
Why?
|
| Female | 24 | 2026 | 70963 | 0.230 |
Why?
|
| Heart Transplantation | 3 | 2021 | 800 | 0.230 |
Why?
|
| Mitochondria, Heart | 2 | 2016 | 58 | 0.220 |
Why?
|
| Hypothermia, Induced | 1 | 2026 | 172 | 0.220 |
Why?
|
| Risk Assessment | 3 | 2025 | 3711 | 0.210 |
Why?
|
| No-Reflow Phenomenon | 2 | 2015 | 9 | 0.210 |
Why?
|
| Prospective Studies | 8 | 2025 | 6459 | 0.200 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 128 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2026 | 266 | 0.200 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 668 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2019 | 521 | 0.190 |
Why?
|
| Blood Proteins | 1 | 2024 | 143 | 0.190 |
Why?
|
| Cardiomegaly | 2 | 2020 | 117 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2026 | 395 | 0.180 |
Why?
|
| Heart Arrest | 1 | 2026 | 356 | 0.180 |
Why?
|
| Tuberculosis, Miliary | 1 | 2021 | 10 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2023 | 412 | 0.170 |
Why?
|
| Prognosis | 4 | 2021 | 4886 | 0.170 |
Why?
|
| Risk Factors | 3 | 2026 | 11074 | 0.160 |
Why?
|
| Anion Transport Proteins | 1 | 2020 | 31 | 0.160 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 38 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 118 | 0.160 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 59 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2020 | 643 | 0.160 |
Why?
|
| Echocardiography | 5 | 2019 | 1125 | 0.160 |
Why?
|
| Heart, Artificial | 1 | 2020 | 46 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 72 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2021 | 544 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 161 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 639 | 0.140 |
Why?
|
| Vasodilation | 1 | 2019 | 175 | 0.140 |
Why?
|
| Cardiology | 1 | 2023 | 514 | 0.140 |
Why?
|
| Retrospective Studies | 4 | 2026 | 17753 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2020 | 401 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 315 | 0.130 |
Why?
|
| Apoptosis | 1 | 2024 | 1827 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 5196 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 335 | 0.130 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 88 | 0.120 |
Why?
|
| Stroke Volume | 5 | 2025 | 541 | 0.120 |
Why?
|
| Swine | 3 | 2015 | 1186 | 0.120 |
Why?
|
| Atrial Appendage | 1 | 2017 | 77 | 0.120 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 468 | 0.120 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 53 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1064 | 0.110 |
Why?
|
| Dabigatran | 1 | 2015 | 26 | 0.110 |
Why?
|
| Insulin | 1 | 2020 | 1149 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2015 | 131 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2304 | 0.110 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2014 | 42 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2014 | 23 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 3061 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 305 | 0.100 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 37 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2015 | 93 | 0.100 |
Why?
|
| Ubiquitin | 1 | 2014 | 128 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 2596 | 0.100 |
Why?
|
| Atrophy | 1 | 2014 | 247 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 116 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2014 | 187 | 0.100 |
Why?
|
| Adult | 8 | 2024 | 31282 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2025 | 970 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 57 | 0.090 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 255 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 1013 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 526 | 0.090 |
Why?
|
| Aorta | 1 | 2015 | 521 | 0.090 |
Why?
|
| Heart Failure, Diastolic | 1 | 2012 | 10 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2014 | 825 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1168 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 17 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2018 | 1077 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 487 | 0.080 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 21 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 417 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2012 | 133 | 0.080 |
Why?
|
| Resistance Training | 1 | 2011 | 26 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 981 | 0.080 |
Why?
|
| Animals | 9 | 2020 | 33912 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2011 | 88 | 0.080 |
Why?
|
| Heart | 2 | 2016 | 650 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 51 | 0.080 |
Why?
|
| Bone Density | 1 | 2012 | 367 | 0.070 |
Why?
|
| Biopsy | 3 | 2019 | 1239 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2014 | 804 | 0.070 |
Why?
|
| Heart Rate | 1 | 2011 | 577 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2011 | 749 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 588 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 887 | 0.070 |
Why?
|
| Cardiac Catheterization | 2 | 2025 | 630 | 0.070 |
Why?
|
| Photoplethysmography | 1 | 2025 | 11 | 0.060 |
Why?
|
| Models, Cardiovascular | 2 | 2018 | 165 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2023 | 12 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 89 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 59 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3147 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3819 | 0.050 |
Why?
|
| Pyrazinamide | 1 | 2021 | 10 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2012 | 194 | 0.040 |
Why?
|
| Isoniazid | 1 | 2021 | 69 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 46 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 35 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 304 | 0.040 |
Why?
|
| Exercise Test | 2 | 2011 | 239 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 149 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2012 | 294 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 58 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 523 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2023 | 798 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 491 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 275 | 0.040 |
Why?
|
| Registries | 1 | 2026 | 1634 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 664 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1129 | 0.030 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 69 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 521 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 111 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 48 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3359 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 480 | 0.030 |
Why?
|
| Mutation | 1 | 2011 | 6099 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 337 | 0.030 |
Why?
|
| Mice | 3 | 2020 | 18301 | 0.030 |
Why?
|
| Free Radicals | 1 | 2016 | 35 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1240 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 134 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 407 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 112 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 104 | 0.030 |
Why?
|
| Greece | 1 | 2015 | 12 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 785 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2020 | 690 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1319 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2015 | 182 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 17 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 242 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 117 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2014 | 7 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 29 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 98 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1680 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 587 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2552 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 142 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 273 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 757 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 4497 | 0.020 |
Why?
|
| Systole | 1 | 2013 | 195 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 429 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3370 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1211 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 83 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 111 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1801 | 0.020 |
Why?
|
| KRIT1 Protein | 1 | 2011 | 1 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 1321 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 272 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 674 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4738 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 242 | 0.020 |
Why?
|
| Anaerobic Threshold | 1 | 2011 | 10 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 423 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 123 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2011 | 77 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 146 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 157 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2011 | 91 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 35 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 152 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 605 | 0.020 |
Why?
|
| Vitamin D | 1 | 2012 | 194 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 573 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 248 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 269 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 152 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 280 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 943 | 0.020 |
Why?
|
| Body Composition | 1 | 2011 | 545 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 398 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 10103 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 597 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2010 | 325 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3360 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 950 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 1246 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2326 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2200 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2595 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4697 | 0.010 |
Why?
|
| United States | 1 | 2020 | 12072 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 892 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 3175 | 0.010 |
Why?
|